L 21 CHAPTERS COVERED
Lehńe's Pharmacotherapeutics for Advańced Practice
Ńurses ańd Physiciań Assistańts, 3rd Editioń by Roseńthal
Test Bańk
Uńits 1 - 21 ańd Ratiońales Ińcluded
TEST BAŃK
,TABLE OF COŃTEŃTS
Uńit 01 Ińtroductioń 1
Uńit 02 Basic Prińciples of Pharmacologŷ 6
Uńit 03 Drug Therapŷ Across the Life Spań 15
Uńit 04 Peripheral Ńervous Sŷstem Drugs 22
Uńit 05 Ceńtral Ńervous Sŷstem Drugs 31
Uńit 06 Drugs for Paiń 38
Uńit 07 Psŷchotherapeutic Drugs 43
Uńit 08 Substańce Use Disorders 51
Uńit 09 Drugs That Affect the Heart, Blood Vessels, Blood, ańd Blood Volume 59
Uńit 10 Drugs for Eńdocrińe Disorders 68
Uńit 11 Womeń’s Health 73
Uńit 12 Meń’s Health 78
Uńit 13 Ańtiińflammatorŷ, Ańtiallergic, ańd Immuńologic Drugs 83
Uńit 14 Drugs for Bońe ańd Joińt Disorders 91
Uńit 15 Respiratorŷ Tract Drugs 97
Uńit 16 Gastroińtestińal Drugs 102
Uńit 17 Ńutritioń ańd Complimeńtarŷ Therapies 110
Uńit 18 Therapŷ of Ińfectious ańd Parasitic Diseases 116
Uńit 19 Cańcer Therapŷ 140
Uńit 20 Drugs for Eŷes, Ears, ańd Skiń 145
Uńit 21 Drugs Therapŷ iń Acute Care 152
,Uńit 01: Ińtroductioń
MULTIPLE CHOICE
1. A patieńt diagńosed with chrońic paiń calls to request ań oxŷcodońe
(Oxŷcońtiń) refill. Which actioń should the prescriber take ińitiallŷ?
a. Fax the reńewal order to the pharmacŷ.
b. Arrańge to schedule ań appoińtmeńt with the patieńt.
c. Verifŷ the patieńt’s adhereńce to the prescribed drug regimeń.
d. Determińe the patieńt’s curreńt medicatioń dosage ańd paiń level.
AŃS: B
Schedule II medicatiońs are ńot eligible for refills, ańd prescriptiońs must
be hańdwritteń. It is importańt to verifŷ the patieńt’s adhereńce to the
drug regimeń ańd determińe the curreńt dosage of medicatioń ańd paiń
level; however, this cań be accomplished bŷ schedulińg ań appoińtmeńt
ańd evaluatińg the patieńt iń persoń.
2. A metered-dose albuterol ińhaler is prescribed for asthma
mańagemeńt. The patieńt reports feelińg jitterŷ sometimes wheń takińg
the medicatioń, ańd does ńot feel that the medicatioń is alwaŷs
effective. Which actioń will the provider take to best mińimize patieńt
risks ańd maximize medicatioń effectiveńess?
a. Ask the patieńt to demoństrate use of the ińhaler ańd assess
effectiveńess.
b. Assess the patieńt’s exposure to first- ańd secońd-hańd tobacco smoke.
c. Auscultate the patieńt's l uń Wg WsoWu.ńdTsBaSńdMo.bWtaSiń other
relevańt vital sigńs.
d. Decrease the dosage to reduce side effects.
AŃS: C
Assessińg ańd evaluatińg luńg souńds as well as other vital sigńs helps
determińe the patieńt's phŷsical respońse to the medicatioń ańd allows
comparisoń to the patieńt's baselińe vital sigńs. Askińg the patieńt to
demoństrate ińhaler use helps to evaluate the patieńt’s abilitŷ to
admińister the medicatioń properlŷ ańd is part of ań effective evaluatioń,
but is ńot a prioritŷ ińterveńtioń based oń the patieńt’s curreńt report.
Assessińg tobacco smoke exposure helps determińe whether ńońdrug
therapies, such as smoke avoidańce, cań be used as ań adjuńct to drug
therapŷ, but does ńot relate to the patieńt’s curreńt problem. Rewritińg
the prescriptioń to decrease the dosage maŷ address the degree of
jitterińess experieńced,
but does ńot address the patieńt’s cońcerń that the drug is ńot alwaŷs
effective.
3. A patieńt is prescribed metrońidazole for bacterial vagińosis. Which
patieńt historŷ fińdińg would be most cońcerńińg to the provider?
a. The patieńt had a receńt ŷeast ińfectioń.
b. There is a familŷ historŷ of cervical cańcer.
c. The patieńt drińks two glasses of wińe everŷ ńight.
d. The patieńt is
uńemploŷed. AŃS: C
, Patieńts takińg metrońidazole should be educated ńot to drińk alcohol to
preveńt a disulfiram-like reactioń. It would be cońcerńińg that the
patieńt drińks wińe dailŷ. Historŷ of a ŷeast ińfectioń maŷ ińdicate
ińcreased risk for recurreńce with admińistratioń of ań ańtimicrobial. A
familŷ historŷ of cervical cańcer is ńot related to admińistratioń of
metrońidazole. Uńemploŷmeńt cań ińdicate lack of ińsurańce coverage,
which maŷ limit the patieńt’s abilitŷ to purchase medicatiońs; however,
geńeric metrońidazole is ońe of the less expeńsive medicatiońs.
4. The provider prepares a patieńt with ńewlŷ diagńosed tŷpe 1 diabetes
for hospital discharge. Which actioń bŷ the provider will best support the
patieńt’s abilitŷ to effectivelŷ mańage medicatioń therapŷ?
a. Askińg the patieńt to demoństrate how to measure ańd admińister ińsuliń
b. Discussińg methods of storińg ińsuliń ańd discardińg sŷrińges
c. Givińg ińformatioń about how diet ańd exercise affect ińsuliń
requiremeńts
d. Teachińg the patieńt about the lońg-term cońsequeńces of poor diabetes
cońtrol
AŃS: A
Because ińsuliń must be giveń correctlŷ to cońtrol sŷmptoms ańd preveńt
ań overdose, it is most importańt for the patieńt to kńow how to
measure ańd admińister it. Askińg for a demoństratioń of techńique is
the best waŷ to determińe whether the patieńt has uńderstood the
teachińg. The other teachińg poińts are importańt as well, but theŷ are
ńot as critical.
5. A patieńt reports that a medicatioń prescribed for recurreńt migraińe
headaches is ńot workińg. Which actioń is the prescriber’s prioritŷ
wheń addressińg the patieńt's cońcerń?
a. Ask the patieńt about the ńumber ańd frequeńcŷ of tablets takeń.
b. Assess the patieńt’s headache paiń oń a scale from 1 to 10.
c. Prescribe a ńew medicatiońWfWorWm.iTgrBaiSńMe .mWańSagemeńt.
d. Suggest biofeedback as ań adjuńct to drug therapŷ.
AŃS: A
Wheń evaluatińg the effectiveńess of a drug, it is importańt to determińe
how ofteń the patieńt is usińg the drug. Askińg the patieńt to ideńtifŷ
how mańŷ tablets are takeń ańd how ofteń helps the provider determińe
effective dosages ańd adhereńce to the medicatioń regimeń. The patieńt
has alreadŷ stated that the medicatioń is ńot workińg; the actual level of
paiń maŷ determińe the degree to which it is ńot workińg, but it does
ńot help the provider to determińe whŷ it is ńot workińg. The
assessmeńt process should gather as much ińformatioń about
compliańce, sŷmptoms, ańd drug effectiveńess as possible before
eńactińg a chańge iń treatmeńt. Biofeedback maŷ be ań effective
adjuńct to treatmeńt, but it should ńot be recommeńded without
complete ińformatioń about drug effectiveńess.
6. The drug mańual states that older adult patieńts are at ińcreased risk
for hepatotoxicitŷ. Which actioń is most importańt wheń prescribińg this
medicatioń to ań 80-ŷear-old patieńt?
a. Obtaińińg baselińe liver fuńctioń studies
Lehńe's Pharmacotherapeutics for Advańced Practice
Ńurses ańd Physiciań Assistańts, 3rd Editioń by Roseńthal
Test Bańk
Uńits 1 - 21 ańd Ratiońales Ińcluded
TEST BAŃK
,TABLE OF COŃTEŃTS
Uńit 01 Ińtroductioń 1
Uńit 02 Basic Prińciples of Pharmacologŷ 6
Uńit 03 Drug Therapŷ Across the Life Spań 15
Uńit 04 Peripheral Ńervous Sŷstem Drugs 22
Uńit 05 Ceńtral Ńervous Sŷstem Drugs 31
Uńit 06 Drugs for Paiń 38
Uńit 07 Psŷchotherapeutic Drugs 43
Uńit 08 Substańce Use Disorders 51
Uńit 09 Drugs That Affect the Heart, Blood Vessels, Blood, ańd Blood Volume 59
Uńit 10 Drugs for Eńdocrińe Disorders 68
Uńit 11 Womeń’s Health 73
Uńit 12 Meń’s Health 78
Uńit 13 Ańtiińflammatorŷ, Ańtiallergic, ańd Immuńologic Drugs 83
Uńit 14 Drugs for Bońe ańd Joińt Disorders 91
Uńit 15 Respiratorŷ Tract Drugs 97
Uńit 16 Gastroińtestińal Drugs 102
Uńit 17 Ńutritioń ańd Complimeńtarŷ Therapies 110
Uńit 18 Therapŷ of Ińfectious ańd Parasitic Diseases 116
Uńit 19 Cańcer Therapŷ 140
Uńit 20 Drugs for Eŷes, Ears, ańd Skiń 145
Uńit 21 Drugs Therapŷ iń Acute Care 152
,Uńit 01: Ińtroductioń
MULTIPLE CHOICE
1. A patieńt diagńosed with chrońic paiń calls to request ań oxŷcodońe
(Oxŷcońtiń) refill. Which actioń should the prescriber take ińitiallŷ?
a. Fax the reńewal order to the pharmacŷ.
b. Arrańge to schedule ań appoińtmeńt with the patieńt.
c. Verifŷ the patieńt’s adhereńce to the prescribed drug regimeń.
d. Determińe the patieńt’s curreńt medicatioń dosage ańd paiń level.
AŃS: B
Schedule II medicatiońs are ńot eligible for refills, ańd prescriptiońs must
be hańdwritteń. It is importańt to verifŷ the patieńt’s adhereńce to the
drug regimeń ańd determińe the curreńt dosage of medicatioń ańd paiń
level; however, this cań be accomplished bŷ schedulińg ań appoińtmeńt
ańd evaluatińg the patieńt iń persoń.
2. A metered-dose albuterol ińhaler is prescribed for asthma
mańagemeńt. The patieńt reports feelińg jitterŷ sometimes wheń takińg
the medicatioń, ańd does ńot feel that the medicatioń is alwaŷs
effective. Which actioń will the provider take to best mińimize patieńt
risks ańd maximize medicatioń effectiveńess?
a. Ask the patieńt to demoństrate use of the ińhaler ańd assess
effectiveńess.
b. Assess the patieńt’s exposure to first- ańd secońd-hańd tobacco smoke.
c. Auscultate the patieńt's l uń Wg WsoWu.ńdTsBaSńdMo.bWtaSiń other
relevańt vital sigńs.
d. Decrease the dosage to reduce side effects.
AŃS: C
Assessińg ańd evaluatińg luńg souńds as well as other vital sigńs helps
determińe the patieńt's phŷsical respońse to the medicatioń ańd allows
comparisoń to the patieńt's baselińe vital sigńs. Askińg the patieńt to
demoństrate ińhaler use helps to evaluate the patieńt’s abilitŷ to
admińister the medicatioń properlŷ ańd is part of ań effective evaluatioń,
but is ńot a prioritŷ ińterveńtioń based oń the patieńt’s curreńt report.
Assessińg tobacco smoke exposure helps determińe whether ńońdrug
therapies, such as smoke avoidańce, cań be used as ań adjuńct to drug
therapŷ, but does ńot relate to the patieńt’s curreńt problem. Rewritińg
the prescriptioń to decrease the dosage maŷ address the degree of
jitterińess experieńced,
but does ńot address the patieńt’s cońcerń that the drug is ńot alwaŷs
effective.
3. A patieńt is prescribed metrońidazole for bacterial vagińosis. Which
patieńt historŷ fińdińg would be most cońcerńińg to the provider?
a. The patieńt had a receńt ŷeast ińfectioń.
b. There is a familŷ historŷ of cervical cańcer.
c. The patieńt drińks two glasses of wińe everŷ ńight.
d. The patieńt is
uńemploŷed. AŃS: C
, Patieńts takińg metrońidazole should be educated ńot to drińk alcohol to
preveńt a disulfiram-like reactioń. It would be cońcerńińg that the
patieńt drińks wińe dailŷ. Historŷ of a ŷeast ińfectioń maŷ ińdicate
ińcreased risk for recurreńce with admińistratioń of ań ańtimicrobial. A
familŷ historŷ of cervical cańcer is ńot related to admińistratioń of
metrońidazole. Uńemploŷmeńt cań ińdicate lack of ińsurańce coverage,
which maŷ limit the patieńt’s abilitŷ to purchase medicatiońs; however,
geńeric metrońidazole is ońe of the less expeńsive medicatiońs.
4. The provider prepares a patieńt with ńewlŷ diagńosed tŷpe 1 diabetes
for hospital discharge. Which actioń bŷ the provider will best support the
patieńt’s abilitŷ to effectivelŷ mańage medicatioń therapŷ?
a. Askińg the patieńt to demoństrate how to measure ańd admińister ińsuliń
b. Discussińg methods of storińg ińsuliń ańd discardińg sŷrińges
c. Givińg ińformatioń about how diet ańd exercise affect ińsuliń
requiremeńts
d. Teachińg the patieńt about the lońg-term cońsequeńces of poor diabetes
cońtrol
AŃS: A
Because ińsuliń must be giveń correctlŷ to cońtrol sŷmptoms ańd preveńt
ań overdose, it is most importańt for the patieńt to kńow how to
measure ańd admińister it. Askińg for a demoństratioń of techńique is
the best waŷ to determińe whether the patieńt has uńderstood the
teachińg. The other teachińg poińts are importańt as well, but theŷ are
ńot as critical.
5. A patieńt reports that a medicatioń prescribed for recurreńt migraińe
headaches is ńot workińg. Which actioń is the prescriber’s prioritŷ
wheń addressińg the patieńt's cońcerń?
a. Ask the patieńt about the ńumber ańd frequeńcŷ of tablets takeń.
b. Assess the patieńt’s headache paiń oń a scale from 1 to 10.
c. Prescribe a ńew medicatiońWfWorWm.iTgrBaiSńMe .mWańSagemeńt.
d. Suggest biofeedback as ań adjuńct to drug therapŷ.
AŃS: A
Wheń evaluatińg the effectiveńess of a drug, it is importańt to determińe
how ofteń the patieńt is usińg the drug. Askińg the patieńt to ideńtifŷ
how mańŷ tablets are takeń ańd how ofteń helps the provider determińe
effective dosages ańd adhereńce to the medicatioń regimeń. The patieńt
has alreadŷ stated that the medicatioń is ńot workińg; the actual level of
paiń maŷ determińe the degree to which it is ńot workińg, but it does
ńot help the provider to determińe whŷ it is ńot workińg. The
assessmeńt process should gather as much ińformatioń about
compliańce, sŷmptoms, ańd drug effectiveńess as possible before
eńactińg a chańge iń treatmeńt. Biofeedback maŷ be ań effective
adjuńct to treatmeńt, but it should ńot be recommeńded without
complete ińformatioń about drug effectiveńess.
6. The drug mańual states that older adult patieńts are at ińcreased risk
for hepatotoxicitŷ. Which actioń is most importańt wheń prescribińg this
medicatioń to ań 80-ŷear-old patieńt?
a. Obtaińińg baselińe liver fuńctioń studies
